Fauci: Good Zika Synergy, But Pharma No NIH Substitute
This article was originally published in Scrip
Executive Summary
While there's been some good synergy between the National Institutes of Health (NIH) and biopharmaceutical manufacturers in certain circumstances, like in the case of the current efforts to quickly develop a Zika virus vaccine, industry "will never be a substitute" for the agency, the top US government infectious disease scientist, Anthony Fauci, told lawmakers on Feb. 24.